Pralsetinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of pralsetinib that may be used in the treatment of anaplastic carcinoma, follicular carcinoma, Hurthle cell carcinoma, medullary carcinoma, hepatobiliary cancers, non-small cell lung cancer (NSCLC) and papillary carcinoma.

**Synonyms:** - Gavreto Regimen - Pralsetinib monotherapy